36396-99-3

N⁶-Cyclohexyladenosine is an adenosine receptor agonist. It selectively binds to adenosine A₁ receptors in rat cortical membranes (IC₅₀ = 2.3 nM) over A₂ receptors in rat striatal membranes (IC₅₀ = 870 nM). N⁶-Cyclohexyladenosine decreases heart rate and increases coronary flow in a perfused working rat heart model ex vivo (EC₂₅s = 5 and 860 nM, respectively). In vivo, it decreases heart rate and blood pressure in normotensive rats (EC₂₅s = 2.4 and 4.2 μg/kg, respectively). N⁶-Cyclohexyladenosine (100 μM) induces sleep in rats when administered via basal forebrain infusion. N⁶-Cyclohexyladenosine also decreases locomotor activity in mice (ED₅₀ = 60 μg/kg, i.p.).

N6-Cyclohexyladenosine is a derivative of Adenosine (A280400), and is used testing adenosine A1 and A2A receptor activation for pharmaceuticals such as antidepressants. N6-Cyclohexyladenosine also is used as a JAK2 inhibitor, blocking STAT3 signalling in human cancer cells.

Selective A1 adenosine receptor agonist.

Store at -20°C

[1] A J HUTCHISON. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.[J]. Journal of Pharmacology and Experimental Therapeutics, 1989, 251 1: 47-55.
[2] CARLOS BLANCO-CENTURION. Adenosine and sleep homeostasis in the Basal forebrain.[J]. Journal of Neuroscience, 2006, 26 31: 8092-8100. DOI: 10.1523/jneurosci.2181-06.2006
[3] OLGA NIKODIJEVI?  Kenneth A J  John W Daly. Characterization of the locomotor depression produced by an A2-selective adenosine agonist[J]. FEBS Letters, 1990, 261 1: Pages 67-70. DOI: 10.1016/0014-5793(90)80638-y